Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by pidukson Jun 10, 2024 1:03pm
120 Views
Post# 36081178

Prior to the vote on the Vivo acquisition, management

Prior to the vote on the Vivo acquisition, managementstated publicly they have the support of their 'top 100 shareholders'.   Since the Vivo vote I have removed my support for management based on the cumulative issues I have stated here including my annoucement that management no longer has my support.  I cannot speak on the behalf of others and the decisions they make.   The cumulative pool of retail shareholders has greater voting power than they realize and I merely requesting they join me in voting NO.   

For decades upon decades a company when announcing a stock buy back was telling shareholders the company is undervalued.  The converse also holds true when a company states their stock is undervalued indicating a buy back.   For management to say the stock is under valued before becoming earnings per share positive is borderline sleazy.  
<< Previous
Bullboard Posts
Next >>